No Data
Barclays Downgrades BWX Technologies(BWXT.US) to Sell Rating, Raises Target Price to $90
Barclays Downgrades BWX Technologies to Underweight From Equalweight, Price Target to $90
BWX Technologies Unit BWXT Medical and NorthStar Collaborating to Produce Cancer-Fighting Isotope
Express News | Bwxt Medical and Northstar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production
Small and Mid-Cap Stocks Likely to Beat/miss This Earnings Season - BofA
Express News | BWX Technologies Inc - Bwxt and Wyoming Energy Authority Sign Cooperation Agreement to Examine Potential Construction Options in State